AstraZeneca to buy Alexion for $39 billion to expand in immunology

AstraZeneca to buy Alexion for $39 billion to expand in immunology


Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.

via DigioNews Markets

>>>MY ANOTHER SITE ONLINE MONEY FREE TECH : DROP99FAST

>>READ MORE : DIGIO NEWS

Note : I Hope My My New News Article : AstraZeneca to buy Alexion for $39 billion to expand in immunology Of DigioNews So You Trust My site you are always updated with Latest news Daily news Everyday. Only on DigioNews : AstraZeneca to buy Alexion for $39 billion to expand in immunology